Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions

Arch Neurol. 1974 Jun;30(6):444-7. doi: 10.1001/archneur.1974.00490360020005.
No abstract available

MeSH terms

  • Carbidopa / metabolism
  • Carbidopa / therapeutic use
  • Dihydroxyphenylalanine / blood
  • Dihydroxyphenylalanine / metabolism*
  • Dihydroxyphenylalanine / therapeutic use
  • Dihydroxyphenylalanine / urine
  • Dopa Decarboxylase / blood
  • Dopa Decarboxylase / urine
  • Dopamine / blood
  • Drug Interactions
  • Drug Synergism
  • Homovanillic Acid / blood
  • Homovanillic Acid / urine
  • Humans
  • Hydrazines / metabolism*
  • Parkinson Disease / blood
  • Parkinson Disease / drug therapy
  • Parkinson Disease / metabolism*
  • Parkinson Disease / urine
  • Pyridoxine / metabolism*
  • Pyridoxine / therapeutic use

Substances

  • Hydrazines
  • Dihydroxyphenylalanine
  • Dopa Decarboxylase
  • Pyridoxine
  • Carbidopa
  • Dopamine
  • Homovanillic Acid